Items where authors include "Passweg, J.R."

Export as [feed] Atom [feed] RSS
Number of items: 12.

Article

Gurnari, C. orcid.org/0000-0001-6829-5544, Koster, L., Baaij, L.G.A. et al. (30 more authors) (2024) Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood Advances, 8 (6). pp. 1444-1448. ISSN 2473-9529

Passweg, J.R. orcid.org/0000-0001-7092-3351, Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2024) Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone Marrow Transplantation. ISSN 0268-3369

Passweg, J.R., Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT activity survey. Bone Marrow Transplantation. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2022) Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplantation, 57. pp. 742-752. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2021) Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplantation, 56 (7). pp. 1651-1664. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Basak, G.W. orcid.org/0000-0003-3858-8180 et al. (14 more authors) (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplantation, 54 (10). pp. 1575-1585. ISSN 0268-3369

Miller, P.D.E., Snowden, J.A. orcid.org/0000-0001-6819-3476, De Latour, R.P. et al. (15 more authors) (2019) Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia : a joint study of the autoimmune diseases and severe aplastic anaemia working parties (ADWP/SAAWP) of the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplantation. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Bader, P. et al. (13 more authors) (2018) Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplantation , 53 (9). pp. 1139-1148. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Bader, P. et al. (12 more authors) (2017) Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplantation, 52 (6). pp. 811-817. ISSN 0268-3369

Proceedings Paper

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic hematopoietic cell transplantation for Vexas syndrome: results of a multicenter study from the chronic malignancies and autoimmune disease working parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 708.

Garderet, L., Gras, L., Koster, L. et al. (22 more authors) (2023) Long term outcomes and renal response following autologous stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Cmwp of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 3403.

Robin, M., Iacobelli, S., Passweg, J.R. et al. (22 more authors) (2023) Treosulfan vompared to Busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the chronic malignancies working party of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 473.

This list was generated on Sun Apr 21 11:07:11 2024 BST.